SangStat SangCya
Executive Summary
Company settles patent infringement lawsuits filed by Novartis regarding SangCya oral solution. In the settlement, SangStat acknowledges that Novartis patents are valid, but still asserts that SangCya does not infringe the patents. The company recalled SangCya July 10 after a study in healthy volunteers demonstrated that SangCya is not bioequivalent to Novartis' Neoral oral solution when mixed with apple juice as recommended in its labeling (1"The Pink Sheet" July 17, p. 13). SangStat said the settlement was unrelated to the recall